✦ LIBER ✦

Randomized Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial of Selenomethionine as a Modulator of Efficacy and Toxicity of Chemoradiation in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck

✍ Scribed by Mix, M.D.; Jameson, M.; Tills, M.; Dibaj, S.; Groman, A.; Jaggernauth, W.; Rustum, Y.; Singh, A.K.

Book ID: 122140249
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 76 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.1234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2B Randomized Trial Comparing Conc

Phase 2B Randomized Trial Comparing Concurrent Chemoradiation to 6 Fractions/Week Accelerated Radiation Therapy in Advanced Squamous Cell Carcinomas of Head and Neck

✍ Kainickal, C.T.; Erakotan, G.K.; Kumar, R.R.; Sudha, A.S.; Rafi, M.; Ramadas, K. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck : Results from a phase III randomized trial

✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the

A randomized, double-blind, multicenter,

A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

✍ Hiroyoshi Ohta, Hiroshi Oka, Chie Usui, Masayuki Ohkura, Makoto Suzuki, Kusuki N 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 370 KB

Phase 2 Trial of AT-101 in Combination W

Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC)

✍ Sacco, A.; Nor, J.; Belile, E.; Sukari, A.; Chepeha, D.; Bradford, C.; Eisbruch, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A phase I, open-label study (EGF 100262)

A phase I, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ I. El-Hariry; K. Harrington; J. Bourhis; C. Holford 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 196 KB

A multicenter, randomized, placebo-contr

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

✍ E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB